{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:15:03Z","timestamp":1785366903752,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,27]]},"DOI":"10.7759\/cureus.109744","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:13:32Z","timestamp":1779891212000},"source":"Crossref","is-referenced-by-count":1,"title":["RareCure: An Open-Source Artificial Intelligence Pipeline for Context-Adaptive Treatment Discovery in Rare Solid Tumors"],"prefix":"10.7759","author":[{"given":"Danielmartin","family":"Arogyasami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21400","article-title":"The burden of rare cancers in the United States","volume":"67","author":"DeSantis CE","year":"2017","unstructured":"DeSantis CE, Kramer JL, Jemal A. The burden of rare cancers in the United States. CA Cancer J Clin. 2017, 67:261-72. 10.3322\/caac.21400","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00388-5","article-title":"The value of research collaborations and consortia in rare cancers","volume":"17","author":"Blay JY","year":"2016","unstructured":"Blay JY, Coindre JM, Ducimetiere F, Ray-Coquard I. The value of research collaborations and consortia in rare cancers. Lancet Oncol. 2016, 17:e62-9. 10.1016\/S1470-2045(15)00388-5","journal-title":"Lancet Oncol"},{"key":"ref3","article-title":"Soft Tissue and Bone Tumours, 5th ed","author":"WHO Classification of Tumours Editorial Board","year":"2020","unstructured":"WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours, 5th ed. IARC Press,  Lyon; 2020. https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Soft-Tissue-And-Bone-Tumours-2020."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0035","article-title":"Soft tissue sarcoma, version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"von Mehren M","year":"2022","unstructured":"von Mehren M, Kane JM, Agulnik M, et al.. Soft tissue sarcoma, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022, 20:815-33. 10.6004\/jnccn.2022.0035","journal-title":"J Natl Compr Canc Netw"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3329-2-14","article-title":"The epidemiology of sarcoma","volume":"2","author":"Burningham Z","year":"2012","unstructured":"Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res. 2012, 2:14. 10.1186\/2045-3329-2-14","journal-title":"Clin Sarcoma Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16845","article-title":"Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas","volume":"8","author":"Groisberg R","year":"2017","unstructured":"Groisberg R, Hong DS, Holla V, et al.. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas. Oncotarget. 2017, 8:39254-67. 10.18632\/oncotarget.16845","journal-title":"Oncotarget"},{"key":"ref7","unstructured":"Sijbrandij S. Osteosarc. 2025. (2026). Accessed. May 23, 2026: https:\/\/osteosarc.com."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"Chakravarty D","year":"2017","unstructured":"Chakravarty D, Gao J, Phillips SM, et al.. OncoKB: a precision oncology knowledge base. JCO Precis Oncol. 2017, 1:1-16. 10.1200\/PO.17.00011","journal-title":"JCO Precis Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour SL","year":"2021","unstructured":"Freshour SL, Kiwala S, Cotto KC, et al.. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 2021, 49:D1144-51. 10.1093\/nar\/gkaa1084","journal-title":"Nucleic Acids Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0401","article-title":"pVACtools: a computational toolkit to identify and visualize cancer neoantigens","volume":"8","author":"Hundal J","year":"2020","unstructured":"Hundal J, Kiwala S, McMichael J, et al.. pVACtools: a computational toolkit to identify and visualize cancer neoantigens. Cancer Immunol Res. 2020, 8:409-20. 10.1158\/2326-6066.CIR-19-0401","journal-title":"Cancer Immunol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1012065","article-title":"The ClinicalTrials.gov results database--update and key issues","volume":"364","author":"Zarin DA","year":"2011","unstructured":"Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database--update and key issues. N Engl J Med. 2011, 364:852-60. 10.1056\/NEJMsa1012065","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.3241","article-title":"Association of patient characteristics and tumor genomics with clinical outcomes among patients with non-small cell lung cancer using a clinicogenomic database","volume":"321","author":"Singal G","year":"2019","unstructured":"Singal G, Miller PG, Agarwala V, et al.. Association of patient characteristics and tumor genomics with clinical outcomes among patients with non-small cell lung cancer using a clinicogenomic database. JAMA. 2019, 321:1391-9. 10.1001\/jama.2019.3241","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1800","article-title":"Assessment of deep natural language processing in ascertaining oncologic outcomes from radiology reports","volume":"5","author":"Kehl KL","year":"2019","unstructured":"Kehl KL, Elmarakeby H, Nishino M, et al.. Assessment of deep natural language processing in ascertaining oncologic outcomes from radiology reports. JAMA Oncol. 2019, 5:1421-9. 10.1001\/jamaoncol.2019.1800","journal-title":"JAMA Oncol"},{"key":"ref14","article-title":"ReAct: synergizing reasoning and acting in language models","author":"Yao S","unstructured":"Yao S, Zhao J, Yu D, Du N, Shafran I, Narasimhan K, Cao Y. ReAct: synergizing reasoning and acting in language models. arXiv:2210.03629.","journal-title":"arXiv:2210.03629"},{"key":"ref15","unstructured":"Arogyasami DM. RareCure. an open-source artificial intelligence pipeline for context-adaptive treatment discovery in rare solid tumors. GitHub. (2026). Accessed: May 23, 2026: https:\/\/github.com\/DanielMartin-Arogyasami\/RareCure."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1607591","article-title":"Toward a shared vision for cancer genomic data","volume":"375","author":"Grossman RL","year":"2016","unstructured":"Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, Staudt LM. Toward a shared vision for cancer genomic data. N Engl J Med. 2016, 375:1109-12. 10.1056\/NEJMp1607591","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson V","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, et al.. The immune landscape of cancer. Immunity. 2018, 48:812-30. 10.1016\/j.immuni.2018.03.023","journal-title":"Immunity"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu548","article-title":"OptiType: precision HLA typing from next-generation sequencing data","volume":"30","author":"Szolek A","year":"2014","unstructured":"Szolek A, Schubert B, Mohr C, Sturm M, Feldhahn M, Kohlbacher O. OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics. 2014, 30:3310-6. 10.1093\/bioinformatics\/btu548","journal-title":"Bioinformatics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"Shukla SA","year":"2015","unstructured":"Shukla SA, Rooney MS, Rajasagi M, et al.. Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat Biotechnol. 2015, 33:1152-8. 10.1038\/nbt.3344","journal-title":"Nat Biotechnol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3774","article-title":"CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer","volume":"49","author":"Griffith M","year":"2017","unstructured":"Griffith M, Spies NC, Krysiak K, et al.. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat Genet. 2017, 49:170-4. 10.1038\/ng.3774","journal-title":"Nat Genet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez D","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, et al.. ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res. 2019, 47:D930-40. 10.1093\/nar\/gky1075","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate JG","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, et al.. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2019, 47:D941-7. 10.1093\/nar\/gky1015","journal-title":"Nucleic Acids Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng PC","year":"2003","unstructured":"Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003, 31:3812-4. 10.1093\/nar\/gkg509","journal-title":"Nucleic Acids Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei IA","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, et al.. A method and server for predicting damaging missense mutations. Nat Methods. 2010, 7:248-9. 10.1038\/nmeth0410-248","journal-title":"Nat Methods"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson B","year":"2020","unstructured":"Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 2020, 48:W449-54. 10.1093\/nar\/gkaa379","journal-title":"Nucleic Acids Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2020.06.010","article-title":"MHCflurry 2.0: improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing","volume":"11","author":"O'Donnell TJ","year":"2020","unstructured":"O'Donnell TJ, Rubinsteyn A, Laserson U. MHCflurry 2.0: improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing. Cell Syst. 2020, 11:42-8. 10.1016\/j.cels.2020.06.010","journal-title":"Cell Syst"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney J","year":"2008","unstructured":"Sidney J, Peters B, Frahm N, Brander C, Sette A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 2008, 9:1. 10.1186\/1471-2172-9-1","journal-title":"BMC Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1029","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza FF","year":"2020","unstructured":"Gonzalez-Galarza FF, McCabe A, Santos EJ, et al.. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 2020, 48:D783-8. 10.1093\/nar\/gkz1029","journal-title":"Nucleic Acids Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.09.015","article-title":"Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction","volume":"183","author":"Wells DK","year":"2020","unstructured":"Wells DK, van Buuren MM, Dang KK, et al.. Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction. Cell. 2020, 183:818-34. 10.1016\/j.cell.2020.09.015","journal-title":"Cell"},{"key":"ref30","article-title":"Sentence-BERT: Sentence Embeddings Using Siamese BERT-Networks","author":"Reimers N","year":"2019","unstructured":"Reimers N, Gurevych I. Sentence-BERT: Sentence Embeddings Using Siamese BERT-Networks. Association for Computational Linguistics, Hong Kong, China; 2019."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1200\/PO.16.00046","article-title":"Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins Molecular Tumor Board","volume":"1","author":"Dalton WB","year":"2017","unstructured":"Dalton WB, Forde PM, Kang H, et al.. Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins Molecular Tumor Board. JCO Precis Oncol. 2017, 1:1-19. 10.1200\/PO.16.00046","journal-title":"JCO Precis Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton GM","year":"2013","unstructured":"Frampton GM, Fichtenholtz A, Otto GA, et al.. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013, 31:1023-31. 10.1038\/nbt.2696","journal-title":"Nat Biotechnol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/489637-rarecure-an-open-source-artificial-intelligence-pipeline-for-context-adaptive-treatment-discovery-in-rare-solid-tumors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:13:34Z","timestamp":1779891214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/489637-rarecure-an-open-source-artificial-intelligence-pipeline-for-context-adaptive-treatment-discovery-in-rare-solid-tumors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.109744","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}